CompletedNot Applicable

The Effect of Combined Bilateral Infraorbital and Infratrochlear Nerve Block in Nasal Surgeries

Egypt40 participantsStarted 2024-01-01

Plain-language summary

The aim of the study is to assess the efficacy of adding a pre-emptive combined bilateral infraorbital and infratrochlear nerve blocks with bupivacaine 0.25% in decreasing intraoperative and postoperative analgesics consumption and maintaining intraoperative hemodynamic stability during nasal surgeries.

Who can participate

Age range18 Years – 55 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age group: 18 - 55 years old.
✓. American Society of Anesthesiologists (ASA) Physical Status Class I or II
✓. Scheduled for elective nasal surgery under general anesthesia.

Exclusion criteria

✕. Refusing to participate in the study or inability to provide informed consent.
✕. History of allergy to the medications used in the study.
✕. Contraindications to regional anesthesia (including coagulopathy, INR ≥ 1.4 and local infection).
✕. Compromised renal or liver functions.
✕. History of substance or alcohol abuse.
✕. Pre-existing chronic pain of different etiology.
✕. Psychiatric disorders.
✕. Pregnancy.

What they're measuring

Total amount of intraoperative fentanyl

Timeframe: throughout the surgery

Trial details

NCT IDNCT06174675

SponsorAin Shams University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-07-01

View on ClinicalTrials.gov More Anesthesia trials